Ensysce Biosciences Inc. Common Stock (ENSC)
Stock · NASDAQ · Health Care
$0.518as of 10/16/2026
Price chart
Active signals
ENSC Signal Track Record
How signals performed across all stocks →What ENSC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 28 | -7.5% | 39% | October 8, 2026 |
| Bollinger Band Breakdown | 25 | -13.5% | 20% | July 28, 2026 |
| Bollinger Band Breakout | 15 | -17.5% | 20% | October 9, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -22.6% | 33% | January 28, 2025 |
| Any 20-session window (baseline) | -13.3% | 27% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ENSC
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-do…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 8
- Website
- ensysce.com/
Fundamentals
- 1-day range
- $0.55$0.5988
- Market cap
- $8.06M
- P/E (trailing)
- —
- P/E (forward)
- -11.96
- EPS (trailing)
- $-2.75
- Dividend yield
- —
- Beta
- 1.10
- Avg. volume
- 13.97M
How Ensysce Biosciences Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 30, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Ensysce Biosciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ENSCEnsysce Biosciences Inc. Common Stock$0.518▼ 13.38%Market cap $8.06MP/E —$0.23$2.75
- TRAWTraws Pharma Inc. Common Stock$0.37▼ 7.50%Market cap $8.21MP/E —$0.391$3.23
- SNGXSoligenix Inc. Common Stock$0.35▼ 2.78%Market cap $8.24MP/E —$0.28$1.76
- APREAprea Therapeutics Inc. Common stock$0.584▼ 5.50%Market cap $7.83MP/E —$0.548$1.69
- KAPAKairos Pharma Ltd. Common Stock$0.601▼ 10.43%Market cap $8.35MP/E —$0.7108$9.17
- PCSAProcessa Pharmaceuticals Inc. Common Stock$1.69▲ 0.60%Market cap $7.65MP/E 3.31$1.04$11
- CNSPCNS Pharmaceuticals Inc. Common Stock$4.85▼ 6.30%Market cap $7.65MP/E —$1.9$10.54
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ENSC Ensysce Biosciences Inc. Common Stock | $8.06M | — | $0.518 | ▼ 13.38% | $0.23$2.75 |
| TRAW Traws Pharma Inc. Common Stock | $8.21M | — | $0.37 | ▼ 7.50% | $0.391$3.23 |
| SNGX Soligenix Inc. Common Stock | $8.24M | — | $0.35 | ▼ 2.78% | $0.28$1.76 |
| APRE Aprea Therapeutics Inc. Common stock | $7.83M | — | $0.584 | ▼ 5.50% | $0.548$1.69 |
| KAPA Kairos Pharma Ltd. Common Stock | $8.35M | — | $0.601 | ▼ 10.43% | $0.7108$9.17 |
| PCSA Processa Pharmaceuticals Inc. Common Stock | $7.65M | 3.31 | $1.69 | ▲ 0.60% | $1.04$11 |
| CNSP CNS Pharmaceuticals Inc. Common Stock | $7.65M | — | $4.85 | ▼ 6.30% | $1.9$10.54 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRAYahoo · 9/24/2026
- Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug RegulationYahoo · 9/15/2026
- Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic DrugsYahoo · 9/14/2026
Insider Activity
Insider Actions →- GOWER BOB G · August 7, 2026 · Buy400.0K @ $0.495
- GOWER BOB G · April 23, 2026 · Conversion254.3K
- GOWER BOB G · April 23, 2026 · Buy508.6K @ $0.484
Institutional Ownership
March 31, 2026
- Total shares held
- 463.2K
- Total value held
- $240.6K
- Institutional holders
- 14
- Unknown149.7K
- Unknown86.7K
- Unknown73.9K
- Unknown57.4K
- Unknown24.4K
- Unknown13.6K
- Unknown13.3K
- Unknown13.0K
- Unknown12.9K
- Unknown8.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
ENSC Included in 12 Healthcare Stocks Moving After Market
ENSC was one of 12 healthcare shares that moved in Wednesday’s after‑market session. The move shows that investors are paying attention to the company after the close. With an RSI of 68.2 the stock is in a relatively strong range, and its support level sits at $0.27. The after‑market activity could influence the next day’s trading.
ENSC Included in 12 Healthcare Stocks Moving After Market. ENSC was one of 12 healthcare shares that moved in Wednesday’s after‑market session. The move shows that investors are paying attention to the company after the close. With an RSI of 68.2 the stock is in a relatively strong range, and its support level sits at $0.27. The after‑market activity could influence the next day’s trading.